UniPharma Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 50.65 million compared to TWD 54.47 million a year ago. Net loss was TWD 5.17 million compared to net income of TWD 2.52 million a year ago.

Basic loss per share from continuing operations was TWD 0.15 compared to basic earnings per share from continuing operations of TWD 0.07 a year ago. Diluted loss per share from continuing operations was TWD 0.15 compared to diluted earnings per share from continuing operations of TWD 0.07 a year ago.